PNC Financial Services Group
INO icon

PNC Financial Services Group’s Inovio Pharmaceuticals INO Stock Holding History

PNC Financial Services Group’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$330 Hold
300
– – ﹤0.01% 5049
2026
Q1 		$522 Sell
300
-585
-66% -$963 ﹤0.01% 4906
2025
Q4 		$1.54K Sell
885
-150
-14% -$330 ﹤0.01% 4585
2025
Q3 		$2.42K Sell
1,035
-5,136
-83% -$9.83K ﹤0.01% 4445
2025
Q2 		$12.6K Buy
6,171
+5,647
+1,078% +$10.8K ﹤0.01% 3776
2025
Q1 		$855 Buy
524
+74
+16% +$149 ﹤0.01% 4546
2024
Q4 		$824 Hold
450
– – ﹤0.01% 4463
2024
Q3 		$2.6K Hold
450
– – ﹤0.01% 4224
2024
Q2 		$3.64K Hold
450
– – ﹤0.01% 4086
2024
Q1 		$6.25K Sell
450
-1,217
-73% -$10.5K ﹤0.01% 3895
2023
Q4 		$10.2K Hold
1,667
– – ﹤0.01% 3723
2023
Q3 		$7.78K Hold
1,667
– – ﹤0.01% 3851
2023
Q2 		$8.94K Sell
1,667
-41
-2% -$331 ﹤0.01% 3923
2023
Q1 		$16.8K Hold
1,708
– – ﹤0.01% 3576
2022
Q4 		$32K Sell
1,708
-13
-0.8% -$295 ﹤0.01% 3235
2022
Q3 		$36K Sell
1,721
-33
-2% -$845 ﹤0.01% 3158
2022
Q2 		$36K Buy
1,754
+12
+0.7% +$338 ﹤0.01% 3183
2022
Q1 		$74K Hold
1,742
– – ﹤0.01% 2882
2021
Q4 		$103K Sell
1,742
-294
-14% -$23.6K ﹤0.01% 2676
2021
Q3 		$176K Hold
2,036
– – ﹤0.01% 2278
2021
Q2 		$227K Buy
2,036
+41
+2% +$3.94K ﹤0.01% 2132
2021
Q1 		$222K Sell
1,995
-49
-2% -$6.44K ﹤0.01% 2109
2020
Q4 		$217K Sell
2,044
-833
-29% -$111K ﹤0.01% 2017
2020
Q3 		$400K Buy
2,877
+353
+14% +$73.6K ﹤0.01% 1483
2020
Q2 		$815K Buy
2,524
+1,718
+213% +$276K ﹤0.01% 1126
2020
Q1 		$73K Buy
806
+356
+79% +$21.9K ﹤0.01% 2410
2019
Q4 		$19K Buy
450
+17
+4% +$512 ﹤0.01% 3332
2019
Q3 		$10K Hold
433
– – ﹤0.01% 3555
2019
Q2 		$16K Hold
433
– – ﹤0.01% 3431
2019
Q1 		$20K Hold
433
– – ﹤0.01% 3364
2018
Q4 		$20K Hold
433
– – ﹤0.01% 3302
2018
Q3 		$28K Hold
433
– – ﹤0.01% 3296
2018
Q2 		$20K Hold
433
– – ﹤0.01% 3443
2018
Q1 		$24K Hold
433
– – ﹤0.01% 3343
2017
Q4 		$22K Sell
433
-1,584
-79% -$98.2K ﹤0.01% 3362
2017
Q3 		$154K Buy
2,017
+267
+15% +$19.9K ﹤0.01% 2297
2017
Q2 		$164K Buy
1,750
+83
+5% +$7.1K ﹤0.01% 2249
2017
Q1 		$133K Sell
1,667
-83
-5% -$6.61K ﹤0.01% 2337
2016
Q4 		$146K Sell
1,750
-1,092
-38% -$98.7K ﹤0.01% 2266
2016
Q3 		$317K Sell
2,842
-39
-1% -$4.31K ﹤0.01% 1823
2016
Q2 		$320K Buy
2,881
+873
+43% +$106K ﹤0.01% 1805
2016
Q1 		$210K Buy
2,008
+1,091
+119% +$84.2K ﹤0.01% 2074
2015
Q4 		$75K Hold
917
– – ﹤0.01% 2615
2015
Q3 		$64K Hold
917
– – ﹤0.01% 2759
2015
Q2 		$90K Buy
917
+84
+10% +$8.97K ﹤0.01% 2699
2015
Q1 		$82K Sell
833
-42
-5% -$4.07K ﹤0.01% 2785
2014
Q4 		$97K Sell
875
-42
-5% -$5.13K ﹤0.01% 2494
2014
Q3 		$108K Buy
917
+867
+1,734% +$108K ﹤0.01% 2339
2014
Q2 		$6K Sell
50
-117
-70% -$13.8K ﹤0.01% 3264
2014
Q1 		$26K Hold
167
– – ﹤0.01% 2762
2013
Q4 		$24K Buy
167
+63
+61% +$6.3K ﹤0.01% 2745
2013
Q3 		$10K Buy
+104
New +$8.72K ﹤0.01% 3262

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PNC Financial Services Group's INO Position: Q2 2026 in Review

PNC Financial Services Group held its Inovio Pharmaceuticals (INO) position steady in Q2 2026 at 300 shares worth $330. The position accounts for ﹤0.01% of the portfolio, ranked #5049.

PNC Financial Services Group first reported a position in INO in Q3 2013 and has held it in 52 quarters since. The position peaked at $815K in Q2 2020. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • PNC Financial Services Group held 300 shares of Inovio Pharmaceuticals worth $330 as of Q2 2026.
  • PNC Financial Services Group left its Inovio Pharmaceuticals share count unchanged in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5049 holding.
  • PNC Financial Services Group first reported a position in Inovio Pharmaceuticals in Q3 2013 and has held it in 52 quarters since.
  • PNC Financial Services Group's Inovio Pharmaceuticals position peaked at $815K in Q2 2020.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.